Pharmaceutical formulation
First Claim
1. A multicomponent pharmaceutical dosage form comprisinga) at least one first sub-unit being a drug substance-containing capsule compartment, which is soluble or disintegrable in a patient'"'"'s gastro-intestinal environment for release of the drug substance contained in the capsule compartment, wherein the capsule compartment comprises an extruded and injection molded polymeric composition comprising:
- 1) an Aminoalkyl Methacrylate Copolymer E present in an amount ranging from about 50% to about 90% w/w;
2) at least one dissolution modifying excipient which is polyethylene oxide present in an amount ranging from about 5% to about 30% w/w; and
3) a lubricant present in an amount up to about 30% w/w; and
b) at least one second sub-unit being a solid matrix comprising a polymer and a drug substance, the polymer being soluble, dispersible or disintegrable in a patient'"'"'s gastro-intestinal environment for release of the drug substance contained in the solid matrix; and
further wherein, at least prior to administration to a patient, the sub-units are assembled together into a dosage form.
6 Assignments
0 Petitions
Accused Products
Abstract
The present invention is directed to pharmaceutically acceptable polymeric compositions suitable for injection molding of single or multi-component pharmaceutical dosage forms comprising a plurality of drug substance containing sub-units, being capsule compartments and/or solid sub-units comprising a solid matrix of a polymer which contains a drug substance, the sub-units being connected together in the assembled dosage form by a weld between parts of the assembled dosage form.
104 Citations
23 Claims
-
1. A multicomponent pharmaceutical dosage form comprising
a) at least one first sub-unit being a drug substance-containing capsule compartment, which is soluble or disintegrable in a patient'"'"'s gastro-intestinal environment for release of the drug substance contained in the capsule compartment, wherein the capsule compartment comprises an extruded and injection molded polymeric composition comprising: -
1) an Aminoalkyl Methacrylate Copolymer E present in an amount ranging from about 50% to about 90% w/w; 2) at least one dissolution modifying excipient which is polyethylene oxide present in an amount ranging from about 5% to about 30% w/w; and 3) a lubricant present in an amount up to about 30% w/w; and b) at least one second sub-unit being a solid matrix comprising a polymer and a drug substance, the polymer being soluble, dispersible or disintegrable in a patient'"'"'s gastro-intestinal environment for release of the drug substance contained in the solid matrix; and further wherein, at least prior to administration to a patient, the sub-units are assembled together into a dosage form. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21)
-
-
22. A multicomponent pharmaceutical dosage form comprising
a) at least one first sub-unit being a drug substance-containing capsule compartment, which is soluble or disintegrable in a patient'"'"'s gastro-intestinal environment for release of the drug substance contained in the capsule compartment, wherein the capsule compartment comprises an extruded and injection molded polymeric composition comprising: -
1) an Aminoalkyl Methacrylate Copolymer E present in an amount ranging from about 30% to about 90% w/w; 2) at least one dissolution modifying excipient which is polyethylene oxide present in an amount ranging from about 5% to about 30% w/w; and 3) a lubricant present in an amount up to about 30% w/w; and b) at least one second sub-unit being a solid matrix comprising a polymer and a drug substance, the polymer being soluble, dispersible or disintegrable in a patient'"'"'s gastro-intestinal environment for release of the drug substance contained in the solid matrix; and further wherein, at least prior to administration to a patient, the sub-units are assembled together into a dosage form. - View Dependent Claims (23)
-
Specification